Cortés-Vicente Elena, Turon-Sans Janina, Gelpi Ellen, Clarimón Jordi, Borrego-Écija Sergi, Dols-Icardo Oriol, Illán-Gala Ignacio, Lleó Alberto, Illa Isabel, Blesa Rafael, Al-Chalabi Ammar, Rojas-García Ricard
Neuromuscular Diseases Unit, Department of Neurology, Hospital de la Santa Creu i Sant Pau, Universitat Autònoma de Barcelona, Barcelona, Spain.
Center for Networked Biomedical Research into Rare Diseases (CIBERER), Madrid, Spain.
Dement Geriatr Cogn Disord. 2018;45(3-4):220-231. doi: 10.1159/000488528. Epub 2018 Jun 8.
To determine the motor phenotype and outcome in a clinically ascertained group of patients with motor neuron disease (MND) and frontotemporal dementia (FTD).
This is an observational retrospective clinical study of patients fulfilling the clinical criteria for MND-FTD. A contemporary series of patients with amyotrophic lateral sclerosis (ALS) without dementia were included for comparison. Demographic, clinical, genetic, and neuropathological data were collected. A descriptive and comparative data analysis was performed.
We identified 22 patients with MND-FTD. Selective distal upper limb muscle weakness and atrophy with non-significant lower limb weakness during follow-up was the most frequent motor pattern, present in 18 patients - in 15 of them associated with severe dysphagia. Aspiration pneumonia was the most common cause of death (12/19; 63%) despite gastrostomy. One-third of the patients did not develop upper motor neuron dysfunction. When compared to classic ALS without dementia (n = 162), these features were significantly different. A neuro-pathological examination was performed on 7 patients, and it confirmed the presence of MND with TDP43 protein aggregates in all patients.
The MND-FTD patients frequently displayed a distinctive motor pattern characterized by weakness and atrophy in distal upper limb muscles and dysphagia, with no or little spreading to other regions. These features may help to define specific subgroups of patients, which is important with regard to clinical management, outcome, and research.
确定经临床确诊的运动神经元病(MND)和额颞叶痴呆(FTD)患者的运动表型及预后。
这是一项对符合MND - FTD临床标准患者的观察性回顾性临床研究。纳入一组当代无痴呆的肌萎缩侧索硬化(ALS)患者作为对照。收集人口统计学、临床、遗传学和神经病理学数据,并进行描述性和对比性数据分析。
我们识别出22例MND - FTD患者。随访期间最常见的运动模式是选择性上肢远端肌肉无力和萎缩,下肢无力不明显,18例患者出现这种情况,其中15例伴有严重吞咽困难。尽管进行了胃造瘘术,但吸入性肺炎仍是最常见的死亡原因(12/19;63%)。三分之一的患者未出现上运动神经元功能障碍。与无痴呆的经典ALS患者(n = 162)相比,这些特征有显著差异。对7例患者进行了神经病理学检查,证实所有患者均存在伴有TDP43蛋白聚集物的MND。
MND - FTD患者常表现出一种独特的运动模式,其特征为上肢远端肌肉无力和萎缩以及吞咽困难,且很少或没有扩散到其他部位。这些特征可能有助于定义特定的患者亚组,这对于临床管理、预后及研究都很重要。